Literature DB >> 8143849

Purification and characterization of a ubenimex (Bestatin)-sensitive aminopeptidase B-like enzyme from K562 human chronic myeloid leukemia cells.

M Yamada1, Y Sukenaga, H Fujii, F Abe, T Takeuchi.   

Abstract

A ubenimex-sensitive aminopeptidase B-like enzyme was purified from the non-membrane-bound fraction of K562 cells by a series of chromatographic procedures and slab-gel electrophoresis. The apparent molecular mass of the enzyme was estimated to be 73 kDa by SDS-PAGE. The aminopeptidase activity was activated by chloride ions and inhibited by Zn2+, Cu2+, Cd2+, and p-chloromercuribenzoic acid. Ubenimex was a potent inhibitor of this aminopeptidase in the nanomolar range. The sequence of the N-terminus of the protein was not determined. Partial amino acid sequencing revealed that the N-terminus of this aminopeptidase B-like enzyme was blocked by acylation. The partial sequences of the two fragments produced by CNBr cleavage and an acylamino acid-releasing reaction showed this enzyme to be a new aminopeptidase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143849     DOI: 10.1016/0014-5793(94)80583-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Aminopeptidase B from the rat testis is a bifunctional enzyme structurally related to leukotriene-A4 hydrolase.

Authors:  S Cadel; T Foulon; A Viron; A Balogh; S Midol-Monnet; N Noël; P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

2.  Modeling of human M1 aminopeptidases for in silico screening of potential Plasmodium falciparum alanine aminopeptidase (PfA-M1) specific inhibitors.

Authors:  Shakti Sahi; Sneha Rai; Meenakshi Chaudhary; Vikrant Nain
Journal:  Bioinformation       Date:  2014-08-30

3.  Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions.

Authors:  Mirjana Grujić; Metka Renko
Journal:  Cancer Lett       Date:  2002-08-28       Impact factor: 8.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.